Toggle light / dark theme

How beige fat keeps blood pressure in check

In this report, researchers link thermogenic adipose tissue (brown/beige fat), best known for heat production, to blood-pressure control via direct fat–blood vessel communication. Using mouse models engineered to lose beige fat identity (via adipocyte-specific disruption of PRDM16), they observed elevated arterial pressure alongside perivascular remodeling, including fibrotic tissue accumulation and marked vascular hypersensitivity to the vasoconstrictor hormone angiotensin II. Mechanistically, loss of beige fat identity increased secretion of QSOX1 (quiescin sulfhydryl oxidase 1), which activated pro-fibrotic gene programs in vascular cells and promoted vessel stiffening; blocking this pathway (including genetic removal of QSOX1 in the model) restored healthier vascular signaling and function. The authors characterize this as a previously underappreciated, obesity-independent axis by which the “quality” (thermogenic vs white-like) of perivascular fat influences vascular stiffness and responsiveness to pressor signals, suggesting QSOX1 and related adipose-derived signals as potential precision targets for future antihypertensive therapies.


A mouse aorta with immunofluorescent tagging, emphasizing the close connection between vasculature and fat. (Credit: Cohen lab)

Obesity causes hypertension. Hypertension causes cardiovascular disease. And cardiovascular disease is the leading cause of death worldwide. While the link between fat and high blood pressure is clearly central to this deadly chain, its biological basis long remained unclear. What is it about fat that impacts vascular function and blood pressure control?

Now, a new study demonstrates how thermogenic beige fat—a type of adipose tissue, distinct from white fat, that helps the body burn energy—directly shapes blood pressure control. Building on clinical evidence that people with brown fat have lower odds of hypertension, the researchers created mouse models that cannot form beige fat (the thermogenic fat depot in mice that most closely resembles adult human brown fat) to watch what happens when this tissue is lost. They found that the loss of beige fat increases the sensitivity of blood vessels to one of the most important vasoconstricting hormones (angiotensin II)—and that blocking an enzyme involved in stiffening vessels and disrupting normal signaling can restore healthy vascular function in mice. These results, published in Science (opens in new window), reveal a previously unknown mechanism driving high blood pressure and point toward more precise therapies that target communication between fat and blood vessels.

Year 2100: Future Technologies that Will Rule the World

The androids of the future will be the distant results of synthetic biology and not silicon.


🚀 Step into a world of boundless innovation as we take you on a journey through the awe-inspiring technologies that await humanity in the 22nd century! 🌌 From advancements in space exploration to mind-boggling leaps in artificial intelligence, this captivating video offers a glimpse into the cutting-edge breakthroughs that will redefine the very fabric of human existence.

🌐 Witness the birth of extraterrestrial civilizations as humans venture further into space, exploring distant planets and establishing self-sustaining colonies. Experience the seamless integration of artificial intelligence into our daily lives, transforming how we interact with technology and creating new possibilities for societal progress. Prepare to be amazed by quantum computing’s extraordinary power, revolutionizing problem-solving and opening doors to scientific discoveries previously deemed impossible.

🌿 Delve into the world of sustainable marvels, where eco-friendly innovations mend our relationship with the environment and pave the way for a greener, more harmonious future. Explore the ethical implications of biotechnology advancements, which offer insights into longevity and human potential. This video paints an inspiring picture of the limitless possibilities and profound transformations that lie ahead in the remarkable world of 22nd-century technologies. Like, share, and subscribe to our channel for more captivating glimpses of the ever-evolving world of tomorrow. 🌟🔮🌠 #FutureTechnologies #22ndCenturyInnovations #EmbracingTomorrow

Self-healing composite can make airplane, automobile and spacecraft components last for centuries

Researchers have created a self-healing composite that is tougher than materials currently used in aircraft wings, turbine blades and other applications—and can repair itself more than 1,000 times. The researchers estimate their self-healing strategy can extend the lifetime of conventional fiber-reinforced composite materials by centuries compared to the current decades-long design-life.

The work is published in the journal Proceedings of the National Academy of Sciences.

“This would significantly drive down costs and labor associated with replacing damaged composite components, and reduce the amount of energy consumed and waste produced by many industrial sectors—because they’ll have fewer broken parts to manually inspect, repair or throw away,” says Jason Patrick, corresponding author of the paper and an associate professor of civil, construction and environmental engineering at North Carolina State University.

Engineering the Future: John Cumbers on Synthetic Biology and Sustainability

Please Like 👍 + Share ⭐ + Subscribe ✅

In this episode of the New Earth Entrepreneurs podcast, we sit down with John Cumbers, founder of SynBioBeta, to discuss how synthetic biology is reshaping industries and creating sustainable solutions.

John shares insights into the role of bio-manufacturing in decarbonizing supply chains, government initiatives supporting bio-innovation, and the potential for space applications of synthetic biology.

Learn how SynBioBeta is building a passionate community of changemakers to engineer a better, more sustainable world.

Learn more about SynBioBeta and their upcoming events at: www.synbiobeta.com.
Connect with John on LinkedIn: www.linkedin.com/in/john-cumbers-542220

The New Earth Entrepreneurs Podcast explores social entrepreneurship and corporate sustainability through engaging conversations with visionary leaders.

Synthetic Biology and AI: The Future of Brain and Body Replacement — SciCon 2024

At SciCon 2024, John Cumbers, founder and CEO of SynBioBeta, explores the groundbreaking and controversial potential of synthetic biology and AI in brain and body replacement. He delves into stem cell research and AI’s role in regenerating brain function, while also addressing the provocative idea of gradually replacing parts of the brain and body. Cumbers discusses how these advancements could one day lead to life extension, challenging traditional views on aging, and raising ethical questions about the future of human biology.

SciCon (2024) is ResearchHub’s annual conference, which unites truth-seekers and innovators to push the boundaries of open science.

– ResearchHub’s mission is to accelerate the pace of scientific research. We are building a modern platform where people can collaborate on scientific research more efficiently, much like GitHub has done for software engineering. We believe scientific research should be accessible to everyone, collaborative, and prioritized.

Product: https://www.researchhub.com/
Website: https://researchhub.foundation/
GitHub: https://github.com/ResearchHub

Penn engineers turn toxic fungus into anti-cancer compound

face_with_colon_three year 2025.


Penn-led researchers have turned a deadly fungus into a potent cancer-fighting compound. After isolating a new class of molecules from Aspergillus flavus, a toxic crop fungus linked to deaths in the excavations of ancient tombs, the researchers modified the chemicals and tested them against leukemia cells. The result? A promising cancer-killing compound that rivals FDA-approved drugs and opens up new frontiers in the discovery of more fungal medicines.

“Fungi gave us penicillin,” says Sherry Gao, Presidential Penn Compact Associate Professor in Chemical and Biomolecular Engineering (CBE) and in Bioengineering (BE) and senior author of a new paper in Nature Chemical Biology on the findings. “These results show that many more medicines derived from natural products remain to be found.”

Scientists turn cells’ most mysterious structures into spies on genetic activity

The barrel-shaped structures found by the thousands in most animal cells are one of biology’s biggest mysteries. But although researchers haven’t figured out the function of these “vaults,” they now report a new use for the puzzling particles.


Enigmatic ‘vaults’ can be engineered to eavesdrop on RNA, aiding cancer studies and more.

Chemist proposes shared ‘model proteins’ to improve reproducibility in protein science

Protein scientists could improve reproducibility and coordination across the field by rallying around a small, shared set of “model proteins,” according to a new Perspective by Connecticut College chemist Marc Zimmer.

The article appears in the 40th-anniversary issue of Protein Engineering, Design and Selection. Zimmer argues that protein science is ready to adopt a framework similar to the one that transformed research using model organisms such as fruit flies, mice, yeast and C. elegans.

Those organisms became powerful research tools not only because their biology is conserved, Zimmer notes, but because scientific communities coordinated around them. Shared protocols, databases and benchmarks made results easier to compare, reproduce and build upon.

Collision-induced ribosome degradation driven by ribosome competition and translational perturbations

How cells eliminate inefficient ribosomes.

Inside every cell, ribosomes act as tiny but vital factories that build proteins, translating genetic information into the molecules that sustain life. Although ribosomes share the same basic structure, not all of them work with equal precision. Until now, scientists did not fully understand how cells detect and handle ribosomes that underperform.

Addressing this question, a team of researchers has identified a quality control mechanism that ensures only the most competent ribosomes survive. Their study, published in Nature Communications shows that ribosomes compete during protein synthesis. When translation is disrupted, the less efficient ribosomes are selectively broken down, while the stronger ones continue functioning.

Using biochemical and genetic analyses in yeast, the researchers examined how ribosomes behave when translation is disrupted. The team engineered cells to contain a functional but suboptimal ribosome variant. These slower-moving ribosomes are overtaken on messenger RNA by faster, native ribosomes, causing the two types to collide. Such ribosome-ribosome collisions activate a ubiquitination-dependent quality control pathway that selectively removes the less efficient ribosomes.

The team also explored how external factors, such as the anticancer drug cisplatin affect this process. Cisplatin, known for binding to RNA and DNA, was found to increase ribosome collisions, which in turn promoted ribosome degradation. This insight could improve understanding of how the drug acts inside cells and why it sometimes causes side effects.

The implications of this discovery extend beyond basic biology. By showing how cells maintain the quality of their protein factories, the study provides a foundation for understanding disorders caused by ribosome malfunction, known as ribosomopathies. It may also open the door to new approaches for improving the safety and effectiveness of certain drugs.

Researchers Discover New Way To Wake Up Cancer-Killing T Cells

Researchers at the University of Southampton have identified a new strategy that could strengthen how the immune system responds to cancer.

Reporting their findings in Nature Communications, the scientists describe the use of specially engineered antibodies designed to more effectively switch on T cells that are capable of destroying cancer cells.

These antibodies act by ‘grabbing’ and ‘clustering’ several immune cell receptors at once, increasing the strength of the signal that instructs T cells to attack tumors.

/* */